Key result
Intravenous low-dose dopamine attenuated the hypoxia-induced reduction in spontaneous cardiac baroreflex sensitivity (P < 0.01), specifically improving sensitivity to rising blood pressures.
Why the study?
Does intravenous low-dose dopamine attenuate the reduction in spontaneous cardiac baroreflex sensitivity during hypoxia in healthy adults?
RCT (n=15)
randomized
Does intravenous low-dose dopamine attenuate the reduction in spontaneous cardiac baroreflex sensitivity during hypoxia in healthy adults?
Low-dose dopamine attenuates the hypoxia-induced reduction in spontaneous cardiac baroreflex sensitivity to rising blood pressures in healthy adults, indicating that carotid body chemoreceptors partially mediate this reflex impairment.
Answers are grounded in this paper and cite their sources.
Low-dose dopamine may preserve baroreflex function in hypoxia; extends evidence for carotid body chemoreceptor mediation of autonomic impairment.
The purpose of the present investigation was to examine the contribution of the carotid body chemoreceptors to changes in baroreflex control of heart rate with exposure to hypoxia. We hypothesized spontaneous cardiac baroreflex sensitivity (scBRS) would be reduced with hypoxia and this effect would be blunted when carotid chemoreceptor activity was reduced with low-dose dopamine. Fifteen healthy adults (11 M/4 F) completed two visits randomized to intravenous dopamine or placebo (saline). On each visit, subjects were exposed to 5-min normoxia (~99% SpO2), followed by 5-min hypoxia (~84% SpO2). Blood pressure (intra-arterial catheter) and heart rate (ECG) were measured continuously and scBRS was assessed by spectrum and sequence methodologies. scBRS was reduced with hypoxia (P < 0.01). Using the spectrum analysis approach, the fall in scBRS with hypoxia was attenuated with infusion of low-dose dopamine (P < 0.01). The decrease in baroreflex sensitivity to rising pressures (scBRS "up-up") was also attenuated with low-dose dopamine (P < 0.05). However, dopamine did not attenuate the decrease in baroreflex sensitivity to falling pressures (scBRS "down-down"; P > 0.05). Present findings are consistent with a reduction in scBRS with systemic hypoxia. Furthermore, we show this effect is partially mediated by the carotid body chemoreceptors, given the fall in scBRS is attenuated when activity of the chemoreceptors is reduced with low-dose dopamine. However, the improvement in scBRS with dopamine appears to be specific to rising blood pressures. These results may have important implications for impairments in baroreflex function common in disease states of acute and/or chronic hypoxemia, as well as the experimental use of dopamine to assess such changes.
No takes yet. Share an insight, caveat, or question.
Mozer et al. (2016) conducted an RCT in Healthy adults (hypoxia exposure) (n=15). Intravenous dopamine vs. Placebo (saline) was evaluated on spontaneous cardiac baroreflex sensitivity (scBRS) (p=<0.01). Intravenous low-dose dopamine attenuated the hypoxia-induced reduction in spontaneous cardiac baroreflex sensitivity (P < 0.01), specifically improving sensitivity to rising blood pressures.
Synapse has enriched 10 related papers. Consider them for comparative context: